Literature DB >> 21130514

Altered nerve excitability in subclinical/early diabetic neuropathy: evidence for early neurovascular process in diabetes mellitus?

Jong Seok Bae1, Oeung Kyu Kim, Jae Moon Kim.   

Abstract

We sought to investigate the peripheral nerve excitability property of early diabetic neuropathy (DN) and provide a logical hypothesis regarding the pathophysiology of subclinical/early stage of DN. The automated nerve excitability test (NET) utilizing the threshold tracking technique (TTT) was performed to measure multiple excitability indices in 30 early DN and 30 normal subjects. Early DN was defined as N0 or N1 stage of Dyck's staging method. The protocols calculated strength-duration time constant (SDTC) from duration-charge curve, parameters of threshold electrotonus (TE) and current-threshold relationship (CTR) from sequential sub-threshold current, and recovery cycle (RC) from double supra-threshold stimulation. Each parameter of test was co-analyzed with clinical and laboratory data including age, sex, BMI, HgbA1c, lipid profile, and estimated glomerular filtration rate (eGFR). Compared to normal or N0 groups, N1 group had 'fanning-in' phenomenon in TE, increased refractory period, and decreased supernormality/subnormality. Linear regression showed that parameters associated with vascular factor were significantly related with STDC: absolute TG values were positively associated with STDC, whereas eGFR values were inversely related with STDC. Nerve excitability can be altered even in the early mild DN. The pattern of alteration suggests depolarizing nerve or nerve ischemia in pathophysiology of subclinical/early DN.
Copyright © 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 21130514     DOI: 10.1016/j.diabres.2010.11.008

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  6 in total

Review 1.  Physiology in Medicine: neuromuscular consequences of diabetic neuropathy.

Authors:  Matti D Allen; Timothy J Doherty; Charles L Rice; Kurt Kimpinski
Journal:  J Appl Physiol (1985)       Date:  2016-03-17

2.  Axonal Excitability Does Not Differ between Painful and Painless Diabetic or Chemotherapy-Induced Distal Symmetrical Polyneuropathy in a Multicenter Observational Study.

Authors:  Andreas C Themistocleous; Alexander G Kristensen; Roma Sola; Sandra S Gylfadottir; Kristine Bennedsgaard; Mustapha Itani; Thomas Krøigård; Lise Ventzel; Søren H Sindrup; Troels S Jensen; Hugh Bostock; Jordi Serra; Nanna B Finnerup; Hatice Tankisi; David L H Bennett
Journal:  Ann Neurol       Date:  2022-03-07       Impact factor: 11.274

3.  Prognostic factors of Guillain-Barré syndrome: a 111-case retrospective review.

Authors:  Yitao Zhang; Yanyin Zhao; Yi Wang
Journal:  Chin Neurosurg J       Date:  2018-06-18

4.  Progressive axonal dysfunction precedes development of neuropathy in type 2 diabetes.

Authors:  Jia-Ying Sung; Susanna B Park; Ya-Ting Liu; Natalie Kwai; Ria Arnold; Arun V Krishnan; Cindy S-Y Lin
Journal:  Diabetes       Date:  2012-04-20       Impact factor: 9.461

5.  Glucose concentration in culture medium affects mRNA expression of TRPV1 and CB1 receptors and changes capsaicin toxicity in PC12 cells.

Authors:  Ahmad Mohammadi-Farani; Mahmoud Ghazi-Khansari; Mousa Sahebgharani
Journal:  Iran J Basic Med Sci       Date:  2014-09       Impact factor: 2.699

6.  The Relationship between Dyslipidemia and Acute Axonal Function in Type 2 Diabetes Mellitus In Vivo.

Authors:  Natalie C G Kwai; William Nigole; Ann M Poynten; Christopher Brown; Arun V Krishnan
Journal:  PLoS One       Date:  2016-04-14       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.